Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes

Conclusions/interpretationGAD65-specific immunotherapy has a significant effect on C-peptide retention in individuals with recent-onset type 1 diabetes who have theDR3-DQ2 haplotype.Graphical abstract

http://link.springer.com/10.1007/s00125-020-05227-z

Source: Diabetologia - August 4, 2020 Category: Endocrinology Source Type: research